EVALUATING R&D PREMIUM IN THE INDIAN HEALTH AND PHARMACEUTICALS INDUSTRIES

The economic advantages of research and development (R&D) investment have shown conflicting results in empirical studies. This study aimed to examine a different approach, evaluating R&D premium and cross-sectional variability of equity returns, a particular case for the Indian healthcare i...

Full description

Bibliographic Details
Main Authors: Bhumiswor Sharma, Srikanth Pyati
Format: Article
Language:English
Published: Petra Christian University 2022-10-01
Series:Jurnal Manajemen dan Wirausaha
Subjects:
Online Access:https://jurnalmanajemen.petra.ac.id/index.php/man/article/view/25022